DeepSight Technology Welcomes Steve Sapot as New Sales VP to Drive Innovation

DeepSight Technology Welcomes Steve Sapot as Vice President of Sales

DeepSight Technology, a frontrunner in the field of medical imaging, has recently announced the appointment of Steve Sapot as its Vice President of Sales. This strategic move is set to bolster the company's efforts in advancing its commercial strategy, focusing on the market adoption of its innovative ultrasound solutions. These include the highly anticipated NeedleVue™ LC1 Ultrasound System and the OnPoint™ Imaging technology currently under development.

In his new role, Steve Sapot will play a pivotal part in the company's journey toward enhancing customer engagement and establishing valuable partnerships within the healthcare sector. As a seasoned professional with over a decade of experience in sales and leadership across medical technology, Sapot's expertise is expected to accelerate DeepSight's growth and solidify its position in the competitive landscape of medical imaging.

Experience and Insights

Before joining DeepSight, Mr. Sapot served as the Chief Commercial Officer at Perimeter Medical Imaging AI, where he was instrumental in building effective commercial operations. His tenure at Perimeter lasted from 2020, during which he developed market-ready teams and expanded the company’s operational reach. Furthermore, his experience at Faxitron, a Hologic company, highlighted his ability to lead nationwide capital equipment sales and contribute to the launch of its Breast Surgery franchise post-acquisition.

Steve has also held influential roles at ConMed Electrosurgery and Barrx Medical, where he not only showcased his sales prowess but also managed and cultivated diverse market strategies. His extensive background in commercial leadership positions him as an asset to DeepSight's future initiatives as the company gears up for a broader clinical presence.

Looking Ahead

Commenting on his new role, Steve expressed his enthusiasm: "I'm honored to join DeepSight at such a transformative moment. The technology here has the potential to redefine interventional ultrasound and tool guidance. I'm excited to work with the team to bring these innovations to healthcare providers and the patients they serve."

DeepSight Technology's focus on innovation is encapsulated in its mission to revolutionize patient care through state-of-the-art systems. Their products aim to deliver unprecedented precision and clarity, thereby empowering healthcare providers with the tools necessary to improve patient outcomes. The company is particularly known for its advanced ultrasound solutions, including the NeedleVue™ Ultrasound System designed for enhanced needle guidance and the OnPoint™ Imaging technology that provides high-resolution visualization.

As DeepSight prepares to showcase its groundbreaking innovations at prominent industry events such as CIRSE 2025 in Barcelona and LSI'25 Europe in London, it is clear that the appointment of Steve Sapot is just the beginning of an exciting new chapter for the company. With his leadership, the organization aims to engage more deeply with healthcare providers and expand its clinical footprint.

For further information about DeepSight Technology and its transformative solutions, you can visit their official website DeepSight. This new phase in the company's growth promises to bring vital advancements in medical imaging technology and enhance the quality of care in various medical fields.